Loading…
Picard Medical, Inc. is projected to decline to $4.32 by 2027, a -16% move from its current price of $5.13. PMI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.70 | $5.13 | $5.58 | -0.09% |
| Aug 6 | $4.53 | $5.12 | $5.78 | -0.18% |
| Aug 7 | $4.41 | $5.12 | $5.94 | -0.27% |
| Aug 8 | $4.30 | $5.11 | $6.07 | -0.37% |
| Aug 9 | $4.21 | $5.11 | $6.19 | -0.46% |
| Aug 10 | $4.13 | $5.10 | $6.30 | -0.55% |
| Aug 11 | $4.06 | $5.10 | $6.40 | -0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.06 | $5.10 | $6.40 | -0.64% |
| Week 2 | $3.67 | $5.06 | $6.98 | -1.27% |
| Week 3 | $3.39 | $5.03 | $7.46 | -1.91% |
| Week 4 | $3.17 | $5.00 | $7.88 | -2.53% |
| Week 5 | $2.99 | $4.97 | $8.26 | -3.16% |
| Week 6 | $2.83 | $4.94 | $8.61 | -3.77% |
| Week 7 | $2.69 | $4.90 | $8.95 | -4.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Picard Medical, Inc., together with its subsidiaries, designs, manufactures, production, supply, marketing, and sale of medical device products.
The company offers SynCardia TAH, an artificial heart for patients that are designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally.
The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc. (PMI) is a healthcare stock with a current price of $0.0879 and a market cap of $9.03M, ranking 4933 by market capitalization. The near-term market position reflects a small-cap healthcare name with limited liquidity and a relatively low price level.
Forecasts show a mixed near-term path through 2026-2029, then a clearer bullish tilt starting in 2030. In 2026 the avg price is forecast at $0.0879 with a max of $0.1133, and in 2027-2029 the avg prices range from $0.0764 to $0.0759, all with neutral sentiment. From 2030 onward, the model projects growing averages (e.g., 2030 avg $0.1095, 2031 avg $0.1201) and bullish sentiment, culminating in 2050 with avg $0.2712 and ROI of 208.6%.
A major floor 99.7% below — a decisive break under it would weaken the trend.
The nearest floor, 97.3% below — buyers have tended to step in here.
Resistance now sits 93.8% below — it may act as fresh support.
A major level 78.9% below — it may now act as a floor.
Key PMI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PMI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.088 | Buy | $0.0898 | Buy |
| MA 10 | $0.0951 | Buy | $0.0992 | Buy |
| MA 20 | $0.125 | Buy | $0.1197 | Buy |
| MA 50 | $0.1644 | Buy | $0.2233 | Buy |
| MA 100 | $0.4704 | Buy | $0.6088 | Buy |
| MA 200 | $1.67 | Buy | $1.54 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.07 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -82.23 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -41.33 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -2.27 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 50.00 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.09 | Buy |
| ADX (14) | 29.37 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is BEARISH with RSI14 at 30.
SMA50 is $0.1761 and SMA200 is $2.00, indicating a wide gap between near-term momentum and longer-term trend. The stock sits on support at $0.088 and faces resistance at $0.32; the 30-day price range runs from $0.0451 to $0.1714, underscoring developing volatility with an annualized volatility of 200%.
With the current price near the $0.088 support, downside pressure remains given the bearish sentiment and tight near-term range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.1399 | $5.13 | $6.55 | 0% | Neutral | |
| $2.91 | $4.32 | $6.96 | -16% | Bearish | |
| $2.85 | $4.65 | $8.14 | -9% | Neutral | |
| $2.45 | $4.35 | $8.10 | -15% | Bearish | |
| $3.17 | $6.08 | $11.91 | +19% | Neutral | |
| $3.34 | $6.91 | $14.12 | +35% | Bullish | |
| $2.47 | $5.49 | $11.65 | +7% | Neutral | |
| $2.44 | $5.41 | $11.88 | +6% | Neutral | |
| $2.32 | $5.16 | $11.68 | +1% | Neutral | |
| $2.41 | $5.35 | $12.31 | +4% | Neutral | |
| $3.01 | $6.69 | $15.38 | +30% | Bullish | |
| $6.70 | $14.89 | $34.24 | +190% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.1399 | $5.13 | $6.04 | +0.00% |
| September 2026 | $3.61 | $4.49 | $5.88 | -12.54% |
| October 2026 | $3.72 | $4.72 | $6.36 | +5.17% |
| November 2026 | $3.75 | $4.84 | $6.67 | +2.60% |
| December 2026 | $3.56 | $4.67 | $6.55 | -3.63% |
Click any year to see its month-by-month PMI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PMI price prediction for 2026 points to an average of $5.13 (low $0.1399, high $6.55) — a potential gain of 0% on today's $5.13. A consolidation phase looks the most probable path here.
In 2027, PMI is projected to trade between $2.91 and $6.96, averaging $4.32 — a potential decline of -16% from today's $5.13. That is -16% versus the projected 2026 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Picard Medical, Inc.'s 2028 outlook centres on $4.65, within a $2.85 to $8.14 range. That is up +8% on the projected 2027 average. That marks a -9% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, PMI could reach as high as $8.10, with a base case around $4.35 and support toward $2.45 — roughly -15% from $5.13. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect PMI to range from $3.17 to $11.91 through 2030. The $6.08 average target implies a +19% move from current prices. That is up +40% on the projected 2029 average. A consolidation phase looks the most probable path here.
The PMI price prediction for 2031 points to an average of $6.91 (low $3.34, high $14.12) — a potential gain of +35% on today's $5.13. Momentum favours further upside here.
In 2032, PMI is projected to trade between $2.47 and $11.65, averaging $5.49 — a potential gain of +7% from today's $5.13. That is -21% versus the projected 2031 average. A consolidation phase looks the most probable path here.
Picard Medical, Inc.'s 2033 outlook centres on $5.41, within a $2.44 to $11.88 range. That is -1% versus the projected 2032 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2034, PMI could reach as high as $11.68, with a base case around $5.16 and support toward $2.32 — roughly +1% from $5.13. A consolidation phase looks the most probable path here.
Expect PMI to range from $2.41 to $12.31 through 2035. The $5.35 average target implies a +4% move from current prices. That is up +4% on the projected 2034 average. Price action looks broadly range-bound.
The PMI price prediction for 2040 points to an average of $6.69 (low $3.01, high $15.38) — a potential gain of +30% on today's $5.13. Buyers look set to stay in control over this stretch.
In 2050, PMI is projected to trade between $6.70 and $34.24, averaging $14.89 — a potential gain of +190% from today's $5.13. That is up +123% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PMI today (≈ 194.931774 PMI) could be worth
$2,901.6
+$1,901.6 (+190%) by 2050 · US Dollar
Based on the average projected PMI price of $14.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PMIwould be worth at today's price.
$1,000 invested in PMI on Aug 29, 2025 (≈ 217.864917 PMI) would be worth
$1,117.65
+$117.65 (+11.8%) today · 1.12× · US Dollar
Based on a PMI entry price of $4.59 vs. today's $5.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.088 | $58,295.45 | +5729.5% |
| 1 month ago | $0.172 | $29,825.58 | +2882.6% |
| 3 months ago | $0.439 | $11,685.65 | +1068.6% |
| 6 months ago | $2.07 | $2,478.26 | +147.8% |
| All time ago | $4.59 | $1,117.65 | +11.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PMI forecast.
Our base-case forecast reaches $10.00 around 2050.
Implied market cap at $10.00: $20.54M
The multi-year forecast shows a shift to bullish momentum beginning in 2030, with 2030 avg $0.1095 and ROI 24.5%. The year 2031 continues the bullish path with avg $0.1201 and ROI 36.7%. By 2040 the forecast remains bullish with avg $0.1149 and ROI 30.7% as the price trajectory fluctuates, supported by a sentiment of BEARISH turning BULLISH in later years.
By 2050, the model projects a substantial increase to avg $0.2712 and ROI 208.6% with a bullish sentiment, while the max forecast reaches $0.6238. The path to these levels is subject to market conditions and execution risks inherent in long-range projections, and these figures are estimates rather than guarantees.
Tap a question to reveal the answer.
Avg price $0.1095; min $0.0571; max $0.2142; ROI 24.5%; sentiment BULLISH.
Near-term forecasts through 2029 are NEUTRAL (e.g., 2026 avg $0.0879, 2029 avg $0.0759). Longer-term forecasts show bullish momentum from 2030 onward, with 2030 avg $0.1095 and 2050 avg $0.2712 and ROI 208.6%.
2030 max $0.2142; 2040 max $0.2643; 2050 max $0.6238. A move to $0.32 is not forecast in the 2030-2040 window but is possible by 2050 or later given the 2050 max of $0.6238.
Current price $0.0879; Market cap $9.03M.
RSI14 30; sentiment BEARISH. Support $0.088; Resistance $0.32. 30-day range $0.0451–$0.1714; SMA50 $0.1761; SMA200 $2.00; annualized volatility 200%.
Picard Medical, Inc. Community Discussion
0Share your Picard Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.